Table 1.
Baseline characteristics
| Overall (n=126) | 3 Months Prednisolone (n=62) | 6 Months Prednisolone (n=64) | |
|---|---|---|---|
| Male, n (%) | 86 (68) | 39 (63) | 47 (73) |
| Age (yr) median (IQR) | 4.2 (3.2–6.2) | 4.7 (3.2–5.8) | 3.8 (3.2–6.4) |
| BPa (mean ± SD) | |||
| Systolic, Z-value | 1.7±1.3b | 1.7±1.3c | 1.6±1.3d |
| Diastolic, Z-value | 1.6±1.1b | 1.7±1.3c | 1.6±1.0d |
| Serum albumin (g/L) median (IQR) | 14.0 (10.0–16.2) | 14.0 (10.0–17.0) | 13.4 (10.0–16.0) |
| Microscopic hematuriae, n (%) | 40 (33)f | 19 (32)g | 21 (34)h |
| Hospital, n (%) | |||
| University | 14 (11.1) | 5 (8.0) | 9 (14.1) |
| General | 112 (88.9) | 57 (92.0) | 55 (85.9) |
| Descent, n (%) | |||
| Western European | 83 (65.9) | 46 (74.2) | 37 (57.8) |
| Non-Western European | 16 (12.7) | 6 (9.7) | 10 (15.6) |
| Mixed | 13 (10.3) | 3 (4.8) | 10 (15.6) |
| Not reported | 14 (11.1) | 7 (11.3) | 7 (10.9) |
| Quarterly distribution of disease onset, n (%) | |||
| January to March | 25 (19.8) | 14 (22.6) | 11 (17.2) |
| April to June | 24 (19.0) | 11 (17.7) | 13 (20.3) |
| July to September | 40 (31.7) | 19 (30.6) | 21 (32.8) |
| October to December | 37 (29.4) | 18 (29.0) | 19 (29.7) |
a
Lowest BP reported in patient’s chart at diagnosis. Z-values are adjusted for sex, age, and height.33
b
Data available for 123 of 126 patients.
c
Data available for 61 of 62 patients.
d
Data available for 62 of 64 patients.
e
Defined as >5 erythrocytes/field; if cell count not available, ≥+ on dipstick analysis.
f
Data available for 121 of 126 patients.
g
Data available for 59 of 62 patients.
h
Data available for 62 of 64 patients.